MAPT and Alzheimer disease: Since AD patients present dysregulation of cortisol levels and high levels of glucocorticoids promotes tau accumulation and upregulation of aberrant tau phosphorylated species in wild type middle aged rats, we assessed if the Mapt−/− behavioral phenotype was due to changes in the glucocorticoid receptor (GR) signaling [24,25].